...

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >COST-EFFECTIVENESS ANALYSIS OF GAZYVARO IN ASSOCIATION TO CHLORAMBUCIL FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WHEN FULL-DOSE FLUDARABINE IS UNSUITABLE IN FRANCE

【24h】

COST-EFFECTIVENESS ANALYSIS OF GAZYVARO IN ASSOCIATION TO CHLORAMBUCIL FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WHEN FULL-DOSE FLUDARABINE IS UNSUITABLE IN FRANCE

机译：当全剂量氟达拉宾无法在法国使用时，GAZYVARO联合氯丁酸治疗慢性淋巴细胞性白血病的患者的成本效益分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2016年第7期|共1页
作者
Plommet N.; Boissard F.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. COST-EFFECTIVENESS ANALYSIS OF GAZYVARO IN ASSOCIATION TO CHLORAMBUCIL FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WHEN FULL-DOSE FLUDARABINE IS UNSUITABLE IN FRANCE [J] . Plommet N., Boissard F. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：当全剂量氟达拉宾无法在法国使用时，GAZYVARO联合氯丁酸治疗慢性淋巴细胞性白血病的患者的成本效益分析
2. Cost-effectiveness of First-line Chronic Lymphocytic Leukemia Treatments When Full-dose Fludarabine Is Unsuitable [J] . Soini Erkki, Hautala Anne, Poikonen Eira, Clinical therapeutics . 2016,第4期

机译：当全剂量氟达拉滨不合适时，一线慢性淋巴细胞白血病治疗的成本效益
3. Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011. [J] . Morrison VA, Rai KR, Peterson BL, Journal of Clinical Oncology . 2001,第16期

机译：苯丁酸氮芥，氟达拉滨或氟达拉滨或苯丁酸氮芥治疗对慢性淋巴细胞性白血病患者感染的影响：癌症间研究组和白血病B组9011。
4. Efficiency and Toxmcity of the Fludarabine and Cyclo- Phosphamide Combined Therapy in Relapsed/ Resistant Patients with B-cell Chronic Lymphocytic Leukaemia (CLL)-Polish Multicenter Study [C] . M. Kowal, A. Dmoszynska, D. Jawniak, European Haematology Association . 2002

机译：B-Cell慢性淋巴细胞白血病（CLL） - 渗透多中心研究的复发/抗性患者复发/抗性患者的氟氮胺碱和环磷酰胺联合治疗的效率和毒性
5. Differential gene expression in B cell chronic lymphocytic leukemia patients with different clinical outcomes. [D] . Joshi, Avadhut D. 2006

机译：具有不同临床结局的B细胞慢性淋巴细胞性白血病患者的差异基因表达。
6. Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine cyclophosphamide rituximab. A French Innovative Leukemia Organization (FILO) study [O] . Guillaume Cartron, Rémi Letestu, Caroline Dartigeas, 2018

机译：利妥昔单抗暴露增加并不能改善氟达拉滨环磷酰胺利妥昔单抗后慢性淋巴细胞性白血病患者的反应和结局。法国创新型白血病组织（FILO）的研究
7. PCN191 Cost-Effectiveness Analysis Of Obinutuzumab For Previously Untreated Chronic Lymphocytic Leukemia (Cll) In Portuguese Patients That Are Unsuitable For Full-Dose Fludarabine Based Therapy [O] . Paquete A, Miguel LS, Pereira C, 2015

机译：奥比努妥珠单抗治疗不适合全剂量氟达拉滨治疗的葡萄牙患者先前未经治疗的慢性淋巴细胞性白血病（Cll）的PCN191成本-效果分析

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号